You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

treat to target

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis Trial (Treatment target DAS28CRP-LDA, Treatment target SDAI-remission)

Not yet recruiting
  • Rheumatoid Arthritis
  • Treatment target DAS28CRP-LDA
  • Treatment target SDAI-remission
  • (no location specified)
Sep 13, 2023

Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe Trial in Milano (bowel ultrasound, colonoscopy)

Recruiting
  • Ulcerative Colitis Chronic Moderate
  • Ulcerative Colitis Chronic Severe
  • bowel ultrasound
  • colonoscopy
  • Milano, Italy
    Mariangela Allocca
Feb 9, 2023

Psoriatic Arthritis Trial in Norway (Imaging informed treat-to-target, Conventional treat-to-target)

Recruiting
  • Psoriatic Arthritis
  • Imaging informed treat-to-target
  • Conventional treat-to-target
  • Bergen, Norway
  • +11 more
Nov 23, 2022

Polymyalgia Rheumatica Trial in Denmark (Treat-to-target Prednisolone Taper, Usual care)

Recruiting
  • Polymyalgia Rheumatica
  • Treat-to-target Prednisolone Taper
  • Usual care
  • Aalborg, Denmark
  • +7 more
Jan 31, 2023

Gout, Inflammatory Rheumatism, Hyperuricemia Trial in Paris (Cleanweb electronic messaging ePro, Usual follow-up)

Recruiting
  • Gout
  • +3 more
  • Cleanweb electronic messaging ePro
  • Usual follow-up
  • Paris, Ile-De-France, France
  • +1 more
Aug 29, 2022

Systemic Lupus Erythematosus Trial in Germany (Treat-to-target as a new treatment concept)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Treat-to-target as a new treatment concept
  • Freiburg, Baden Wurttemberg, Germany
  • +13 more
Jan 25, 2023

Acute Kidney Injury, Cirrhosis, Portal Hypertension Trial in San Francisco (MAP-Target Algorithm)

Not yet recruiting
  • Acute Kidney Injury
  • +5 more
  • MAP-Target Algorithm
  • San Francisco, California
    University of California San Francisco
Aug 14, 2023

Multicentre ObservatioNal Initiative in Treat to Target Outcomes

Recruiting
  • Psoriatic Arthritis
  • Oxford, Oxfordshire, United Kingdom
    Oxford University Hospitals NHS Trust
May 18, 2022

Gout Trial (Treat-to-target, Treat-to-flare)

Not yet recruiting
  • Gout
  • Treat-to-target
  • Treat-to-flare
  • (no location specified)
Aug 18, 2022

Arthritis, Rheumatoid, Ultrasound, Treat to Target Trial (Ultrasound)

Not yet recruiting
  • Arthritis, Rheumatoid
  • +2 more
  • Ultrasound
  • (no location specified)
Feb 6, 2023

Rheumatoid Arthritis Who Received Structured Treat-to-target

Recruiting
  • Rheumatoid Arthritis
    • Bergen, Norway
    • +10 more
    Mar 22, 2022

    Arthritis, Rheumatoid Trial in Torrance (Rheumatoid arthritis educational booklet, Multidisciplinary rheumatologic care, Nurse

    Not yet recruiting
    • Arthritis, Rheumatoid
    • Rheumatoid arthritis educational booklet
    • +4 more
    • Torrance, California
      The Lundquist Institute at Harbor-UCLA Medical Center
    Apr 5, 2022

    Ulcerative Colitis, Crohn Disease Trial in United States (Pragmatic)

    Recruiting
    • Ulcerative Colitis
    • Crohn Disease
    • Pragmatic
    • Irvine, California
    • +20 more
    Jan 9, 2023

    Rheumatic Arthritis Trial in Germany (Tofacitinib, Etanercept)

    Recruiting
    • Rheumatic Arthritis
    • Berlin, Germany
    • +5 more
    Mar 1, 2022

    Opiate Withdrawal Syndrome Trial in Manchester, London (DMX-1002, Placebo)

    Recruiting
    • Opiate Withdrawal Syndrome
    • Manchester, Greater Mancherster, United Kingdom
    • +1 more
    Jul 29, 2022

    Practice of Treat-to-target on Pediatric Systemic Lupus

    Not yet recruiting
    • Systemic Lupus Erythematosus
      • (no location specified)
      Jun 19, 2021

      Management of Gout Trial (Allopurinol, Antiinflammatory Agent for Gout Flare Prophylaxis)

      Not yet recruiting
      • Management of Gout
      • Allopurinol
      • Antiinflammatory Agent for Gout Flare Prophylaxis
      • (no location specified)
      May 3, 2021

      Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)

      Recruiting
      • Psoriatic Arthritis
      • +2 more
      • Erlangen, Bavaria, Germany
        Universitätsklinikum Erlangen
      Nov 10, 2022

      Rheumatoid Arthritis Trial in Philadelphia (Ultrasound Assessment)

      Recruiting
      • Rheumatoid Arthritis
      • Ultrasound Assessment
      • Philadelphia, Pennsylvania
        Perelman Center for Advanced Medicine
      Mar 22, 2022

      Insomnia, Depression Trial in Palo Alto (Cognitive Behavioral Therapy for Insomnia)

      Recruiting
      • Insomnia
      • Depression
      • Cognitive Behavioral Therapy for Insomnia
      • Palo Alto, California
        Stanford University
      Aug 6, 2021

      Arthritis, Rheumatoid Trial (Learning Collaborative)

      Active, not recruiting
      • Arthritis, Rheumatoid
      • Learning Collaborative
      • (no location specified)
      Jul 20, 2021

      Parkinson Disease Trial in United States (Personal KinetiGraph® (PKG®) Watch, Personal KinetiGraph® (PKG®) Report)

      Terminated
      Has Results
      • Parkinson Disease
      • Personal KinetiGraph® (PKG®) Watch
      • Personal KinetiGraph® (PKG®) Report
      • Fayetteville, Arkansas
      • +16 more
      Jan 12, 2022

      Parkinson Disease Trial (Personal KinetiGraph® (PKG®) System, Personal KinetiGraph® (PKG®) Watch)

      Withdrawn
      • Parkinson Disease
      • Personal KinetiGraph® (PKG®) System
      • Personal KinetiGraph® (PKG®) Watch
      • (no location specified)
      Jan 27, 2021

      Type 2 Diabetes Trial in Beijing (HR17031 injection, INS068 injection, SHR20004 injection)

      Recruiting
      • Type 2 Diabetes
      • HR17031 injection
      • +2 more
      • Beijing, Beijing, China
        Peking university People's Hospital
      Jul 25, 2022

      Bipolar Disorder, Depression Trial in New York (N-acetyl cysteine (NAC))

      Completed
      • Bipolar Disorder
      • Depression
      • N-acetyl cysteine (NAC)
      • New York, New York
        Columbia University Medical Center
      Aug 3, 2021